Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
79,719,412
-
Total 13F shares
-
22,820,749
-
Share change
-
+2,530,828
-
Total reported value
-
$886,801,865
-
Price per share
-
$38.86
-
Number of holders
-
94
-
Value change
-
+$90,209,096
-
Number of buys
-
53
-
Number of sells
-
29
Institutional Holders of Kymera Therapeutics, Inc. - COMMON STOCK (KYMR) as of Q1 2021
As of 31 Mar 2021 Kymera Therapeutics, Inc. - COMMON STOCK (KYMR) had 94 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 22,820,749 shares of stock of the company.
Largest 10 holders included BVF INC/IL, Redmile Group, LLC, FMR LLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, Deer IX & Co. Ltd., BlackRock Inc., STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, and WELLINGTON MANAGEMENT GROUP LLP.
This table shows 94 institutional shareholders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.